Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peiran Yang

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Frontiers in Cardiovascular Medicine|December 13, 2021
Single-Cell Transcriptome Profiles Reveal Fibrocytes as Potential Targets of Cell Therapies for Abdominal Aortic AneurysmBolun Li, Xiaomin Song, Wenjun Guo, et al.
Journal of Translational Internal Medicine|October 3, 2024
Inhibition of heterogeneous nuclear ribonucleoproteins A1 and oxidative stress reduces glycolysis <i>via</i> pyruvate kinase M2 in chronic thromboembolic pulmonary hypertensionLianhua Liu, Wenyi Pang, Jixiang Liu, et al.
Pulmonary Circulation|August 4, 2025
The Role of the Pulmonary Vascular Microenvironment in Chronic Thromboembolic Pulmonary HypertensionLu Sun, Han Tian, Jixiang Liu, et al.
Frontiers in Neuroscience|March 16, 2017
[Pyr<sup>1</sup>]Apelin-13<sub>(1-12)</sub> Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr<sup>1</sup>]Apelin-13Peiran Yang, Rhoda E Kuc, Aimée L Brame, et al.
Frontiers in Pharmacology|March 15, 2021
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis <i>In Vitro</i> and Induces Vasodilatation Without Desensitisation <i>In Vivo</i>Cai Read, Duuamene Nyimanu, Peiran Yang, et al.
Pharmacological Reviews|September 8, 2019
International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide LigandCai Read, Duuamene Nyimanu, Thomas L Williams, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Cross-species analysis of experimental PH at single cell resolution reveals prominent contributions <i>Ednrb</i> <sup>+</sup> EC and <i>Dhcr24</i> <sup>+</sup> macrophage populationsBolun Li, Yanjiang Xing, Yitian Zhou, et al.
Respiration; International Review of Thoracic Diseases|August 13, 2024
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Disease: Success Rate and Complications among Different Patient PopulationsZhihui Fu, Wanmu Xie, Qian Gao, et al.
Basic & Clinical Pharmacology & Toxicology|March 23, 2019
Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivoCai Read, Peiran Yang, Rhoda E Kuc, et al.
American Journal of Respiratory and Critical Care Medicine|June 16, 2015
Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertensionElaine Soon, Alexi Crosby, Mark Southwood, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Frontiers in Cardiovascular Medicine|December 13, 2021
Single-Cell Transcriptome Profiles Reveal Fibrocytes as Potential Targets of Cell Therapies for Abdominal Aortic AneurysmBolun Li, Xiaomin Song, Wenjun Guo, et al.
Journal of Translational Internal Medicine|October 3, 2024
Inhibition of heterogeneous nuclear ribonucleoproteins A1 and oxidative stress reduces glycolysis <i>via</i> pyruvate kinase M2 in chronic thromboembolic pulmonary hypertensionLianhua Liu, Wenyi Pang, Jixiang Liu, et al.
Pulmonary Circulation|August 4, 2025
The Role of the Pulmonary Vascular Microenvironment in Chronic Thromboembolic Pulmonary HypertensionLu Sun, Han Tian, Jixiang Liu, et al.
Frontiers in Neuroscience|March 16, 2017
[Pyr<sup>1</sup>]Apelin-13<sub>(1-12)</sub> Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr<sup>1</sup>]Apelin-13Peiran Yang, Rhoda E Kuc, Aimée L Brame, et al.
Frontiers in Pharmacology|March 15, 2021
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis <i>In Vitro</i> and Induces Vasodilatation Without Desensitisation <i>In Vivo</i>Cai Read, Duuamene Nyimanu, Peiran Yang, et al.
Pharmacological Reviews|September 8, 2019
International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide LigandCai Read, Duuamene Nyimanu, Thomas L Williams, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Cross-species analysis of experimental PH at single cell resolution reveals prominent contributions <i>Ednrb</i> <sup>+</sup> EC and <i>Dhcr24</i> <sup>+</sup> macrophage populationsBolun Li, Yanjiang Xing, Yitian Zhou, et al.
Respiration; International Review of Thoracic Diseases|August 13, 2024
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Disease: Success Rate and Complications among Different Patient PopulationsZhihui Fu, Wanmu Xie, Qian Gao, et al.
Basic & Clinical Pharmacology & Toxicology|March 23, 2019
Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivoCai Read, Peiran Yang, Rhoda E Kuc, et al.
American Journal of Respiratory and Critical Care Medicine|June 16, 2015
Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertensionElaine Soon, Alexi Crosby, Mark Southwood, et al.
Pageof 9